cbdMD, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-12-31; filed 2026-02-17.
0001437749-26-004343
ITEM 1A. Risk FactorsCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-14.
0001437749-26-017042
ITEM 1A. Risk FactorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 2 previous paragraphs and 2 current paragraphs.
1 unchanged; 0 reworded; 1 added; 1 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of the 2025 10-K. Investors should carefully consider the risks described in the 2025 10-K, together with all of the other information included in this Quarterly Report, including our financial statements and the related notes and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section, before deciding whether to invest in our securities. See also “Liquidity and Capital Resources” above for additional discussion of factors that may affect our results of operations and financial condition.
Removed paragraphs (1)
Previous report
We desire to take advantage of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Accordingly, in addition to the disclosure below, we incorporate by reference the risk factors disclosed in Part I, Item 1A of our 2025 10-K. See also “Liquidity and Capital Resources” above.